Immunovant, Inc.

NASDAQ:IMVT

25.86 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -109.119-87.15-75.319-51.418-58.662-73.937-59.432-63.227-47.928-40.373-47.171-41.385-37.703-30.471-28.158-31.776-20.789-26.708-20.551-0.0110.1250.183-0-0.009-0.006-0.004
Depreciation & Amortization 0.0890.080.0640.5250.0560.0530.3410.0490.0460.0440.0390.0330.0280.0260.0220.0190.0140.010.0060000000
Deferred Income Tax 0036.139-11.270-24.869000000-0.5710.571-0.7650.689-0.2320.02600000000
Stock Based Compensation 12.69313.4550.010.010.0110.0110.0080.0090.0087.68711.86310.1598.3613.8615.4885.9923.3613.9811.840.0010.0030.001-0000
Change In Working Capital 2.65-2.655.625-6.253-12.27615.536-4.2487.59319.258-33.4562.038-0.2428.8214.5250.6981.978-6.8518.741-4.4760.0040.2570.011-0.0040.0010.0020
Accounts Receivables 0.4172.927-4.1210.266-0.561-0.1420.0022.9459.764-0.947-11.633-7.531-0.177-0.21-0.06700000000000
Change In Inventory 000000000011.633000000000000000
Change In Accounts Payables 9.3693.8793.392-3.704-18.91525.011-12.6296.4726.518-17.48514.871-0.4271.1350.6750.337-3.823-2.0746.811-1.6370000000
Other Working Capital -7.136-9.4566.354-2.8157.2-24.8698.379-1.8242.976-15.024-12.8330.1857.6863.850.3615.801-4.7771.93-2.8390.004-0.0080.011-0.0040.0010.0020
Other Non Cash Items 5.046.87510.78811.0980.29325.1590.2870.2840.2810.2790.275-0.461.0170.2740.2190.2830.2790.1520.1310.002-0.683-0.4130.001-00.001-0.001
Operating Cash Flow -88.647-76.199-59.699-47.098-60.06-47.37-55.793-46.395-20.186-65.819-32.956-31.895-20.047-21.214-22.496-22.815-24.218-13.798-23.05-0.004-0.302-0.23-0-0.007-0.003-0.005
Investing Activities:
Investments In Property Plant And Equipment -0.196-0.182-0.15-0.131-0.034-0.045-0.026-0.098-0.031-0.042-0.118-0.074-0.044-0.018-0.095-0.029-0.039-0.047-0.01-0-00-0-000
Acquisitions Net 00000000000000000000000000
Purchases Of Investments 00000000000000000000000000
Sales Maturities Of Investments 00000000000000000000000000
Other Investing Activites 00000000000000000000000000
Investing Cash Flow -0.196-0.182-0.15-0.131-0.034-0.045-0.026-0.098-0.031-0.042-0.118-0.074-0.044-0.018-0.095-0.029-0.039-0.047-0.01-0-00-0-000
Financing Activities:
Debt Repayment 0000000000000000-0.202000000000
Common Stock Issued -0.6860.686474.29-2.9010.1480.8970.50.13100.021-2000200.0380.0910.7630188.753131.0300000000
Common Stock Repurchased 00000000000000000000000000
Dividends Paid 00000000000000000000000000
Other Financing Activities 0.730.6861.545469.8440.1480.890.23370.63100.0212000200.0380.0910.7630.446-0.201193.5530.1010.1090.0335.303-0.1770.0140.0080.005
Financing Cash Flow 0.730.6861.545469.8440.1480.890.23370.63100.02100200.0380.0910.7630.446188.35193.5530.1010.1090.033116.994-0.1770.0140.0080.005
Other Information:
Effect Of Forex Changes On Cash 1.0490.3352.732-1.606-0.086-0.047-0.492.697-1.215-0.772-0.1120.0200000000000000
Net Change In Cash -87.064-75.36-55.572-321.346-60.032-46.572-56.07626.835-21.432-66.612-33.186-31.949179.947-21.141-21.828-22.398164.093179.708-22.9590.105-0.3021.764-0.1770.0070.0050
Cash At End Of Period 472.941560.005635.365-51.418269.928329.96376.532432.608405.773427.205493.817527.003558.952379.005400.146421.974444.372280.279100.5710.1241.611.9120.1480.0120.0050